Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020
DUBLIN, Ireland and CHICAGO, Oct. 19, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical […]
Spartacus Acquisition Corporation Announces Closing of $200,000,000 Initial Public Offering
New York, NY, Oct. 19, 2020 (GLOBE NEWSWIRE) — Spartacus Acquisition Corporation (NASDAQ: TMTSU) (the “Company”) announced today that it […]
